Generation and functional confirmation of a conditional null PPARγ allele in mice
Julie R. Jones
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
Search for more papers by this authorKathy D. Shelton
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
Search for more papers by this authorYoufei Guan
Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee
Veterans Administration Medical Center, Nashville, Tennessee
Search for more papers by this authorMatthew D. Breyer
Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee
Veterans Administration Medical Center, Nashville, Tennessee
Search for more papers by this authorCorresponding Author
Mark A. Magnuson
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
747 Light Hall, Vanderbilt University Medical Center, Nashville, TN 37232-0615Search for more papers by this authorJulie R. Jones
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
Search for more papers by this authorKathy D. Shelton
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
Search for more papers by this authorYoufei Guan
Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee
Veterans Administration Medical Center, Nashville, Tennessee
Search for more papers by this authorMatthew D. Breyer
Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee
Veterans Administration Medical Center, Nashville, Tennessee
Search for more papers by this authorCorresponding Author
Mark A. Magnuson
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
747 Light Hall, Vanderbilt University Medical Center, Nashville, TN 37232-0615Search for more papers by this author
LITERATURE CITED
- Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585–595.
- Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137: 354–366.
- Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. 1992. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879–887.
- Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803–812.
- Jiang C, Ting AT, Seed B. 1998. PPAR-γagonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82–86.
- Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813–819.
- Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Nagai R, Tobe K, Kimura S, Kadowaki T. 1999. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4: 597–609.
- Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953–12956.
- Miles PD, Barak Y, He W, Evans RM, Olefsky JM. 2000. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest 105: 287–292.
- Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4: 611–617.
- Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, Eng C. 1999. Loss-of-function mutations in PPARγ associated with human colon cancer. Mol Cell 3: 799–804.
- Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. 1999. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383–389.
- Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79: 1147–1156.
- Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK. 1993. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J Biol Chem 268: 26817–26820.
- Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK. 1995. Structural organization of mouse peroxisome proliferator-activated receptor γ (m PPARγ) gene: alternative promoter use and different splicing yield two m PPARγ isoforms. Proc Natl Acad Sci U S A 92: 7921–7925.
Citing Literature
